The document is an intimation to the stock exchanges (BSE and NSE) regarding the availability of recordings for an earnings call.
The event type was a Q2 FY27 Earnings Call, conducted on November 04, 2026.
The stated purpose of the intimation is compliance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
The earnings call was held on the same day as the disclosure date (November 04, 2026).
The management participant mentioned is Rajesh U. Shanoy, who is the Company Secretary and Compliance officer and signed the letter.
Both audio and video recordings of the earnings call are available.
The recordings are hosted on the company's investor relations webpage at: https://www.biocon.com/investor-relations/financial-information/quarterly-reports/fy-2026-27/.
The recordings are also available on the company's main website at www.biocon.com.
The document does not disclose any financial figures, guidance, or strategic updates; it solely provides the link to the recordings.
Additional Notes Section
The document is a formal compliance letter addressed to the BSE and NSE.
No financial data, presentation decks, or transcripts were included in this specific announcement; it only provides the link to where the recordings can be accessed.
The letter includes a digital signature from the Company Secretary, confirming its authenticity.
